DYN Insider Transactions — Page 7
706 retained open-market purchase and sale rows from SEC Forms 3, 4 and 5, newest first. This page shows rows 601–700; provenance stays internal.
| Insider profile | Role | Date | Transaction | Shares | Price |
|---|---|---|---|---|---|
| McNeill Jonathan | Chief Business Officer | 2024-01-26 | Sale | 178.0 | $25.14 |
| McNeill Jonathan | Chief Business Officer | 2024-01-26 | Sale | 19,822.0 | $24.52 |
| Scalzo Richard William | SVP, Head of Finance & Admin. | 2024-01-26 | Sale | 13,000.0 | $24.34 |
| Kersten Dirk | Director,TenPercentOwner | 2024-01-09 | Purchase | 1,428,571.0 | $17.5 |
| Kersten Dirk | Director,TenPercentOwner | 2024-01-09 | Purchase | 285,714.0 | $17.5 |
| Brumm Joshua T | CEO & President | 2024-01-04 | Sale | 38,301.0 | $19.05 |
| Brumm Joshua T | CEO & President | 2024-01-04 | Sale | 180,235.0 | $18.4 |
| Beskrovnaya Oxana | Chief Scientific Officer | 2024-01-04 | Sale | 42,453.0 | $18.13 |
| McNeill Jonathan | Chief Business Officer | 2024-01-04 | Sale | 2,009.0 | $18.04 |
| Brumm Joshua T | CEO & President | 2024-01-03 | Sale | 16,026.0 | $20.5 |
| Brumm Joshua T | CEO & President | 2024-01-03 | Sale | 19,775.0 | $19.03 |
| Brumm Joshua T | CEO & President | 2024-01-03 | Sale | 15,382.0 | $18.34 |
| Beskrovnaya Oxana | Chief Scientific Officer | 2024-01-03 | Sale | 5,361.0 | $20.5 |
| Beskrovnaya Oxana | Chief Scientific Officer | 2024-01-03 | Sale | 24,583.0 | $19.05 |
| Beskrovnaya Oxana | Chief Scientific Officer | 2024-01-03 | Sale | 15,382.0 | $18.34 |
| McNeill Jonathan | Chief Business Officer | 2024-01-03 | Sale | 10,300.0 | $19.03 |
| McNeill Jonathan | Chief Business Officer | 2024-01-03 | Sale | 7,691.0 | $18.34 |
| Scalzo Richard William | SVP, Head of Finance & Admin. | 2024-01-03 | Sale | 13,000.0 | $18.81 |
| McNeill Jonathan | Chief Business Officer | 2024-01-02 | Sale | 11,900.0 | $13.1 |
| Scalzo Richard William | See Remarks | 2023-12-14 | Sale | 2,376.0 | $12.02 |
| Farwell Wildon | Chief Medical Officer | 2023-12-12 | Sale | 978.0 | $10.55 |
| Scalzo Richard William | See Remarks | 2023-12-11 | Sale | 1,380.0 | $10.72 |
| McNeill Jonathan | Chief Business Officer | 2023-12-11 | Sale | 1,245.0 | $10.72 |
| HIGH SUSANNA GATTI | Chief Operating Officer | 2023-12-11 | Sale | 1,616.0 | $10.72 |
| Farwell Wildon | Chief Medical Officer | 2023-12-11 | Sale | 1,688.0 | $10.72 |
| Brumm Joshua T | See Remarks | 2023-12-11 | Sale | 7,585.0 | $10.72 |
| Beskrovnaya Oxana | Chief Scientific Officer | 2023-12-11 | Sale | 1,467.0 | $10.72 |
| Scalzo Richard William | See Remarks | 2023-12-06 | Sale | 1,872.0 | $12.01 |
| Scalzo Richard William | See Remarks | 2023-12-04 | Sale | 681.0 | $12.01 |
| HIGH SUSANNA GATTI | Chief Operating Officer | 2023-11-02 | Sale | 9,939.0 | $7.4 |
| Scalzo Richard William | See Remarks | 2023-09-18 | Sale | 1,290.0 | $9.41 |
| McNeill Jonathan | Chief Business Officer | 2023-09-18 | Sale | 1,261.0 | $9.41 |
| HIGH SUSANNA GATTI | Chief Operating Officer | 2023-09-18 | Sale | 2,672.0 | $9.41 |
| Brumm Joshua T | See Remarks | 2023-09-18 | Sale | 12,032.0 | $9.41 |
| Beskrovnaya Oxana | Chief Scientific Officer | 2023-09-18 | Sale | 1,436.0 | $9.41 |
| Farwell Wildon | Chief Medical Officer | 2023-09-12 | Sale | 1,707.0 | $10.41 |
| Scalzo Richard William | See Remarks | 2023-09-12 | Sale | 1,397.0 | $10.41 |
| McNeill Jonathan | Chief Business Officer | 2023-09-12 | Sale | 1,266.0 | $10.41 |
| HIGH SUSANNA GATTI | Chief Operating Officer | 2023-09-12 | Sale | 1,635.0 | $10.41 |
| Brumm Joshua T | See Remarks | 2023-09-12 | Sale | 7,672.0 | $10.41 |
| Beskrovnaya Oxana | Chief Scientific Officer | 2023-09-12 | Sale | 1,484.0 | $10.41 |
| Scalzo Richard William | See Remarks | 2023-06-15 | Sale | 10,000.0 | $12.03 |
| Scalzo Richard William | See Remarks | 2023-06-13 | Sale | 40,000.0 | $12.89 |
| Scalzo Richard William | See Remarks | 2023-06-13 | Sale | 1,390.0 | $12.43 |
| McNeill Jonathan | See Remarks | 2023-06-13 | Sale | 1,259.0 | $12.43 |
| HIGH SUSANNA GATTI | Chief Operating Officer | 2023-06-13 | Sale | 1,625.0 | $12.43 |
| Farwell Wildon | Chief Medical Officer | 2023-06-13 | Sale | 1,698.0 | $12.43 |
| Beskrovnaya Oxana | Chief Scientific Officer | 2023-06-13 | Sale | 1,475.0 | $12.43 |
| McNeill Jonathan | See Remarks | 2023-06-12 | Sale | 1,000.0 | $13.0 |
| Brumm Joshua T | See Remarks | 2023-06-12 | Sale | 187,748.0 | $12.61 |
| Brumm Joshua T | See Remarks | 2023-06-09 | Sale | 76,582.0 | $13.34 |
| Brumm Joshua T | See Remarks | 2023-06-08 | Sale | 14,189.0 | $13.47 |
| Brumm Joshua T | See Remarks | 2023-06-08 | Sale | 46,811.0 | $13.15 |
| Scalzo Richard William | See Remarks | 2023-03-14 | Sale | 1,311.0 | $13.33 |
| McNeill Jonathan | See Remarks | 2023-03-14 | Sale | 1,209.0 | $13.33 |
| HIGH SUSANNA GATTI | Chief Operating Officer | 2023-03-14 | Sale | 1,559.0 | $13.33 |
| Farwell Wildon | Chief Medical Officer | 2023-03-14 | Sale | 7,441.0 | $13.33 |
| Brumm Joshua T | See Remarks | 2023-03-14 | Sale | 7,318.0 | $13.33 |
| Beskrovnaya Oxana | Chief Scientific Officer | 2023-03-14 | Sale | 1,416.0 | $13.33 |
| McNeill Jonathan | See Remarks | 2023-03-13 | Sale | 1,000.0 | $13.0 |
| McNeill Jonathan | See Remarks | 2023-01-18 | Sale | 10,000.0 | $14.03 |
| McNeill Jonathan | See Remarks | 2023-01-09 | Sale | 30,150.0 | $11.57 |
| Rhodes Jason P | Director | 2022-12-12 | Purchase | 934,581.0 | $10.7 |
| Atlas Venture Fund XI, L.P. | TenPercentOwner | 2022-12-12 | Purchase | 934,581.0 | $10.7 |
| Atlas Venture Opportunity Fund I, L.P. | TenPercentOwner | 2022-12-12 | Purchase | 934,581.0 | $10.7 |
| Atlas Venture Associates Opportunity I, L.P. | TenPercentOwner | 2022-12-12 | Purchase | 934,581.0 | $10.7 |
| Atlas Venture Associates Opportunity I, LLC | TenPercentOwner | 2022-12-12 | Purchase | 934,581.0 | $10.7 |
| Atlas Venture Associates XI, LLC | TenPercentOwner | 2022-12-12 | Purchase | 934,581.0 | $10.7 |
| Atlas Venture Associates XI, L.P. | TenPercentOwner | 2022-12-12 | Purchase | 934,581.0 | $10.7 |
| Atlas Venture Opportunity Fund II, L.P. | TenPercentOwner | 2022-12-12 | Purchase | 934,581.0 | $10.7 |
| Atlas Venture Associates Opportunity II, LLC | TenPercentOwner | 2022-12-12 | Purchase | 934,581.0 | $10.7 |
| Atlas Venture Associates Opportunity II, LP | TenPercentOwner | 2022-12-12 | Purchase | 934,581.0 | $10.7 |
| Scalzo Richard William | See Remarks | 2022-12-12 | Sale | 312.0 | $10.87 |
| McNeill Jonathan | See Remarks | 2022-12-12 | Sale | 472.0 | $10.87 |
| HIGH SUSANNA GATTI | Chief Operating Officer | 2022-12-12 | Sale | 751.0 | $10.87 |
| Farwell Wildon | Chief Medical Officer | 2022-12-12 | Sale | 628.0 | $10.87 |
| Brumm Joshua T | See Remarks | 2022-12-12 | Sale | 3,322.0 | $10.87 |
| Beskrovnaya Oxana | Chief Scientific Officer | 2022-12-12 | Sale | 680.0 | $10.87 |
| Brumm Joshua T | See Remarks | 2022-10-10 | Sale | 195,800.0 | $12.46 |
| Brumm Joshua T | See Remarks | 2022-10-07 | Sale | 14,200.0 | $13.37 |
| Scalzo Richard William | See Remarks | 2022-03-11 | Sale | 308.0 | $8.73 |
| McNeill Jonathan | See Remarks | 2022-03-11 | Sale | 481.0 | $8.73 |
| HIGH SUSANNA GATTI | Chief Operating Officer | 2022-03-11 | Sale | 765.0 | $8.73 |
| Farwell Wildon | Chief Medical Officer | 2022-03-11 | Sale | 640.0 | $8.73 |
| Brumm Joshua T | See Remarks | 2022-03-11 | Sale | 3,384.0 | $8.73 |
| Beskrovnaya Oxana | Chief Scientific Officer | 2022-03-11 | Sale | 693.0 | $8.73 |
| Farwell Wildon | Chief Medical Officer | 2022-03-02 | Sale | 5,617.0 | $8.56 |
| HIGH SUSANNA GATTI | Chief Operating Officer | 2021-09-23 | Sale | 2,451.0 | $17.22 |
| Scalzo Richard William | See Remarks | 2021-09-21 | Sale | 492.0 | $16.11 |
| McNeill Jonathan | See Remarks | 2021-09-21 | Sale | 729.0 | $16.11 |
| Brumm Joshua T | See Remarks | 2021-09-21 | Sale | 4,584.0 | $16.11 |
| Beskrovnaya Oxana | Chief Scientific Officer | 2021-09-21 | Sale | 827.0 | $16.11 |
| Scalzo Richard William | See Remarks | 2021-09-20 | Sale | 367.0 | $15.61 |
| McNeill Jonathan | See Remarks | 2021-09-20 | Sale | 545.0 | $15.61 |
| Brumm Joshua T | See Remarks | 2021-09-20 | Sale | 3,425.0 | $15.61 |
| Beskrovnaya Oxana | Chief Scientific Officer | 2021-09-20 | Sale | 617.0 | $15.61 |
| RA CAPITAL MANAGEMENT, L.P. | TenPercentOwner | 2020-09-21 | Purchase | 660,000.0 | $19.0 |
| Kolchinsky Peter | TenPercentOwner | 2020-09-21 | Purchase | 660,000.0 | $19.0 |
| Shah Rajeev M. | TenPercentOwner | 2020-09-21 | Purchase | 660,000.0 | $19.0 |
| Vida Ventures II, LLC | TenPercentOwner | 2020-09-21 | Purchase | 22,005.0 | $19.0 |